| | Separate cash flow for the year ended December 31, 2020 |  |   |   |   |   |   |   |  |   |   | Notes | Dec. 31, 2020 |   | Dec. 31, 2019 |  |   |   |   | EGP Thousands |   | EGP Thousands |  |   |   |   |   |   |   |  |   | Cash flow from operating activities |   |   |   |   |  |   | Profit before income tax |   | 15,297,119 |   | 16,537,441 |  |   | Adjustments to reconcile net profit to net cash provided by operating activities |   |   |   |   |  |   | Fixed assets depreciation | 24 | 677,501 |   | 576,544 |  |   | Impairment charge for credit losses (Loans and advances to customers and banks) | 12 | 4,777,592 |   | 1,610,878 |  |   | Other provisions charges | 29 | 1,232,731 |   | 461,869 |  |   | Impairment charge for credit losses (due from banks) | 12 | 6,514 |   | 9,503 |  |   | Impairment charge for credit losses (financial investments) | 12 | 205,182 |   | (184,921) |  |   | Impairment charge for other assets | 23 | 69,217 |   | (93,313) |  |   | Exchange revaluation differences for financial assets at fair value through OCI | 21 | 249,642 |   | 1,593,030 |  |   | Intangible assets amortization |   | - |   | 238,715 |  |   | Impairment charge financial assets at fair value through OCI | 21 | 79,126 |   | 47,197 |  |   | Utilization of other provisions | 29 | (2,382) |   | (28,135) |  |   | Other provisions no longer used | 29 | (13,273) |   | (6,910) |  |   | Exchange differences of other provisions | 29 | (7,193) |   | (110,062) |  |   | (Profits) losses from selling property, plant and equipment | 11 | (1,094) |   | (1,439) |  |   | (Profits) losses from selling financial investments | 21 | (1,018,469) |   | (497,894) |  |   | Shares based payments |   | 552,438 |   | 464,539 |  |   | Released (Impairment) charges of investments in associates and subsidiaries | 21 | 16,511 |   | - |  |   | Operating profits before changes in operating assets and liabilities |   | 22,121,162 |   | 20,617,042 |  |   |   |   |   |   |   |  |   | Net decrease (increase) in assets and liabilities |   |   |   |   |  |   | Due from banks | 15 | (10,899,927) |   | (8,870,547) |  |   | Financial assets at fair value through P&L | 21 | 58,822 |   | 2,318,924 |  |   | Derivative financial instruments | 20 | 16,109 |   | (2,910) |  |   | Loans and advances to banks and customers | 18 - 19 | (4,276,558) |   | (14,533,328) |  |   | Other assets | 40 | 649,301 |   | 162,502 |  |   | Due to banks | 25 | (2,995,046) |   | 4,550,788 |  |   | Due to customers | 26 | 35,602,869 |   | 19,143,183 |  |   | Income tax obligations paid |   | (3,779,782) |   | (3,625,579) |  |   | Other liabilities | 28 | (7,700,878) |   | 1,894,934 |  |   | Net cash used in (generated from) operating activities |   | 28,796,072 |   | 21,655,009 |  |   |   |   |   |   |   |  |   | Cash flow from investing activities |   |   |   |   |  |   | Proceeds from investments in associates. |   | 750 |   | - |  |   | Payments for investment in subsidiaries and associates. |   | (721,352) |   | - |  |   | Payment for purchases of property, plant, equipment and branches constructions |   | (987,061) |   | (1,301,415) |  |   | Proceeds from selling property, plant and equipment | 11 | 1,094 |   | 1,439 |  |   | Proceeds from redemption of financial assets at amortized cost | 21 | 82,203,469 |   | 43,937,957 |  |   | Payment for purchases of financial assets at amortized cost | 21 | - |   | (76,516,842) |  |   | Payment for purchases of financial assets at fair value through OCI | 21 | (112,382,696) |   | (50,954,311) |  |   | Proceeds from selling financial assets at fair value through OCI |   | 54,970,226 |   | 54,813,449 |  |   | Net cash generated from (used in) investing activities |   | 23,084,430 |   | (30,019,723) |  |   |  |   | Separate cash flow for the year ended December 31, 2020 (Cont.) | 
  |  |   |   |   |   |   |   |  |   |   |   | Dec. 31, 2020 |   | Dec. 31, 2019 |  |   |   |   | EGP Thousands |   | EGP Thousands |  |   |   |   |   |   |   |  |   | Cash flow from financing activities |   |   |   |   |  |   | Received (Repaid) in long term loans | 27 | 4,474,200 |   | (448,783) |  |   | Dividend paid |   | (3,370,464) |   | (2,700,544) |  |   | Capital increase |   | 85,992 |   | 105,413 |  |   | Net cash generated from (used in) financing activities |   | 1,189,728 |   | (3,043,914) |  |   |   |   |   |   |   |  |   |   |   |   |   |   |  |   | Net increase (decrease) in cash and cash equivalent during the year |   | 53,070,230 |   | (11,408,628) |  |   | Beginning balance of cash and cash equivalent |   | 22,895,017 |   | 34,303,645 |  |   | Cash and cash equivalent at the end of the year |   | 75,965,247 |   | 22,895,017 |  |   |   |   |   |   |   |  |   | Cash and cash equivalent comprise: |   |   |   |   |  |   | Cash and balances at the central bank | 15 | 33,572,597 |   | 28,273,962 |  |   | Due from banks | 16 | 87,020,365 |   | 28,370,183 |  |   | Treasury bills and other governmental notes | 17 | 39,464,714 |   | 27,634,062 |  |   | Obligatory reserve balance with CBE | 15 | (27,610,380) |   | (22,397,310) |  |   | Due from banks with maturities more than three months |   | (16,280,760) |   | (10,593,903) |  |   | Treasury bills with maturity more than three months |   | (40,201,289) |   | (28,391,977) |  |   | Total cash and cash equivalent |   | 75,965,247 |   | 22,895,017 |  |   |   |   |   |   |   | 
  |   |   |   |   |   |   |   |